Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives
- PMID: 10750312
- DOI: 10.1093/geront/40.1.43
Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives
Abstract
Two hundred and three children and siblings of patients with Alzheimer's disease (AD) (age range: 30-92 years, 75% female) were surveyed regarding potential predictive testing options for the disorder. A mailed questionnaire posed various hypothetical scenarios and assessed the following variables: interest in testing, perceptions of its pros and cons, and psychological and demographic predictors of test intentions. In 5 of 6 scenarios, a majority of participants expressed intentions to pursue testing, with perceived pros outweighing cons. The most important reasons for seeking testing were informing later-life decisions and planning future AD care. Predictors of test intentions were male gender, information-seeking style, higher perceived AD threat, and appraisal of test pros versus cons. Situational factors such as available treatment options and certainty of test information also affected responses. Results suggest a positive view of predictive testing, with its limitations and risks underrated. Study findings may inform AD genetic counseling and health education efforts.
Similar articles
-
[Attitudes towards predictive genetic testing for Alzheimer's disease].Z Gerontol Geriatr. 2006 Jun;39(3):233-9. doi: 10.1007/s00391-006-0377-3. Z Gerontol Geriatr. 2006. PMID: 16794889 German.
-
Areas of intervention for genetic counselling of dementia: cross-cultural comparison between Italians and Americans.Patient Educ Couns. 2006 Dec;64(1-3):285-93. doi: 10.1016/j.pec.2006.03.008. Epub 2006 Jul 21. Patient Educ Couns. 2006. PMID: 16860519
-
Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):329-36. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10207637
-
New insights into genetic aspects of Alzheimer's disease. Does genetic information make a difference in clinical practice?Postgrad Med. 2000 Oct;108(5):119-22, 125-6, 129. doi: 10.3810/pgm.2000.10.1267. Postgrad Med. 2000. PMID: 11043085 Review.
-
Genetic testing for Alzheimer's disease: trends, challenges and ethical considerations.Curr Opin Psychiatry. 2020 Mar;33(2):136-140. doi: 10.1097/YCO.0000000000000573. Curr Opin Psychiatry. 2020. PMID: 31770136 Review.
Cited by
-
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.Alzheimers Res Ther. 2024 Jan 2;16(1):1. doi: 10.1186/s13195-023-01364-w. Alzheimers Res Ther. 2024. PMID: 38167083 Free PMC article.
-
The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services.J Behav Med. 2015 Oct;38(5):706-14. doi: 10.1007/s10865-015-9630-9. Epub 2015 Mar 27. J Behav Med. 2015. PMID: 25813985
-
Interest in and Experience with Genetic Testing for Late-Onset Medical Conditions: Results from the National Poll on Healthy Aging.J Prev Alzheimers Dis. 2024;11(4):1079-1086. doi: 10.14283/jpad.2024.69. J Prev Alzheimers Dis. 2024. PMID: 39044520 Free PMC article.
-
Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors.Genet Med. 2011 Jun;13(6):597-605. doi: 10.1097/GIM.0b013e31821d69b8. Genet Med. 2011. PMID: 21577118 Free PMC article.
-
The Impact of Test Outcome Certainty on Interest in Genetic Testing Among College Women.J Genet Couns. 2003 Apr;12(2):131-50. doi: 10.1023/A:1022607223097. J Genet Couns. 2003. PMID: 26140845
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous